Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Vaccines for whooping cough contain 3 to 5 protective antigens

Vaccines for whooping cough contain three to five protective antigens, the presence of which are critical to the vaccine's effectiveness. But one of the antigens, pertactin, which had been present in almost all isolates of Bordetella pertussis in the US as late as 2010, is now absent from more than half of them, according to a paper published ahead of print in Clinical and Vaccine Immunology.

13 Dec 2013

Cinnamon, nutmeg, marshmallows provide more than taste of holiday spice

Cinnamon, nutmeg and marshmallows provide more than a taste of holiday spice or a sugar rush. They are the ingredients for recipes for trendy risky games played by many to disasterous consequences.

13 Dec 2013

AudioEducator presents audio conferences on latest CPT coding updates for 2014

The providers want accurate reimbursement, whereas the payers want efficient claims processing. The ever-changing CPT® code set doesn't make your job easy. According to the American Medical Association (AMA), there will be 335 total code changes in 2014, to include 175 new codes, 107 revised codes, and 47 deleted codes.

12 Dec 2013

New book provides cutting-edge methods for generating and characterizing mouse cancer models

The laboratory mouse is an important model for addressing questions in cancer biology. In recent years, the questions have become more refined, and mouse models are increasingly being used to develop and test cancer therapeutics.

12 Dec 2013

Wolfberries appear to interact with vaccine to offer protection against flu virus in older mice

In a study of older mice, wolfberries appear to interact with the influenza vaccine to offer additional protection against the flu virus. The research, led by scientists at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University, suggests the wolfberry may increase the activity of dendritic cells, which play an important role in the ability of the immune system to defend against viral infections.

12 Dec 2013

New drug-resistant strain of bird flu appears to retain ability to cause serious disease in humans

Researchers at the Icahn School of Medicine at Mount Sinai reported that a virulent new strain of influenza - the virus that causes the flu - appears to retain its ability to cause serious disease in humans even after it develops resistance to antiviral medications. The finding was included in a study that was published today in the journal Nature Communications.

12 Dec 2013

GSK's FluLaval Quadrivalent vaccine effective in reducing flu cases in children

GlaxoSmithKline plc announced today that a peer-reviewed study issued online by the New England Journal of Medicine has reported that GSK's FluLaval® Quadrivalent reduced flu cases among children ages 3-8 by 55.4% overall and lowered the risk of developing moderate-to-serious flu illness by 73.1%.

12 Dec 2013

Probe mimics pathogen's amino acids, solving mystery behind Chlamydiae cell wall

Biochemical sleuthing by an Indiana University graduate student has ended a nearly 50-year-old search to find a megamolecule in bacterial cell walls commonly used as a target for antibiotics, but whose presence had never been identified in the bacterium responsible for the most commonly reported sexually transmitted disease in the United States.

12 Dec 2013

New antimicrobial coating prevents infections during cold winter months

With cold and flu season now in full swing, all-natural wellness provider Neutra Corp. (OTCBB: NTRR) is working quickly to deliver a revolutionary new antimicrobial coating that could soon prove to be the best defense against infections and viruses in the most notorious hotspot for the spread of these diseases: the classroom.

11 Dec 2013

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG) today announced that results from two studies of REVLIMID (lenalidomide) combinations in patients with diffuse large B-cell lymphoma (DLBCL) were presented at the American Society of Hematology annual meeting in New Orleans, La.

11 Dec 2013

New study aims to determine prevalence of pediatric chronic fatigue syndrome in Chicago area youth

The prevalence of chronic fatigue syndrome in children and the significant impairment it causes to their physical functioning, school attendance and performance, and extracurricular activities, are at the root of a new Chicago-based study led by DePaul University psychologist Leonard A. Jason.

11 Dec 2013

Experimental compound reduces joint inflammation in animal models of rheumatoid arthritis

An experimental compound synthesized and developed by scientists from the Florida campus of The Scripps Research Institute has the capacity to significantly reduce joint inflammation in animal models of rheumatoid arthritis, an autoimmune disease that affects more than two million Americans.

11 Dec 2013

Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

Pharmacyclics, Inc. today announced results of 40 clinical, non-clinical and pre-clinical presentations on ibrutinib (IMBRUVICA™) at the 55TH Annual meeting of the American Society of Hematology (ASH) held in New Orleans, Dec 7 - 10, 2013.

11 Dec 2013

Tips to relieve dry skin

Dry skin is a common problem during the winter and its effects can be painful - causing the skin to flake, itch, crack and even bleed. Yet dermatologists say there are ways people can find relief by implementing a few changes to their daily lives.

10 Dec 2013

CUSP project aims to reduce ventilator-associated pneumonia in hospitals

UHC announced its selection as a coordinating entity for a 3-year, $7.3 million contract from the Agency for Healthcare Research and Quality that has been awarded to the Johns Hopkins Armstrong Institute for Patient Safety and Quality to reduce ventilator-associated pneumonia in hospitals.

10 Dec 2013

Preparing for better management of Tamiflu-resistant influenza viruses

Researchers in Umeå and Uppsala have found that residues of the influenza drug Tamiflu in our environment can make the influenza virus in birds resistant. This can have serious consequences in the event of an influenza pandemic. With more than 14 million SEK from the Swedish Research Councils Formas and VR, the research team will now continue their studies with a focus on alternative antiviral drugs.

10 Dec 2013

Children hospitalized for pneumonia have similar outcomes with big gun antibiotics or penicillin

Children hospitalized for pneumonia have similar outcomes, including length of stay and costs, regardless of whether they are treated with "big gun" antibiotics such as ceftriaxone or cefotaxime or more narrowly focused antibiotics such as ampicillin or penicillin, according to a Vanderbilt study published in Pediatrics.

10 Dec 2013

Takeda presents clinical study results of oral proteasome inhibitor MLN9708 in multiple myeloma patients

Takeda Pharmaceutical Company Limited today announced final Phase 1 and preliminary Phase 2 results of a study combining oral investigational MLN9708 administered twice a week with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma.

10 Dec 2013

ImmunoGen presents Phase I trial results of SAR650984 at ASH annual meeting

ImmunoGen, Inc., a biotechnology company that develops targeted, antibody-based anticancer therapeutics, today announced the first clinical findings with SAR650984 reported in an oral presentation at the ASH annual meeting. The data are from an ongoing Phase I trial assessing this CD38-targeting therapeutic antibody in patients with CD38-positive MM or other hematologic malignancy.

10 Dec 2013

MUC5B protein plays key role in many lung-related ailments

An international team of researchers has zeroed in on a protein that plays a key role in many lung-related ailments, from seasonal coughing and hacking to more serious diseases such as MRSA infections and cystic fibrosis.

9 Dec 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Vaccines for whooping cough contain 3 to 5 protective antigens

Cinnamon, nutmeg, marshmallows provide more than taste of holiday spice

AudioEducator presents audio conferences on latest CPT coding updates for 2014

New book provides cutting-edge methods for generating and characterizing mouse cancer models

Wolfberries appear to interact with vaccine to offer protection against flu virus in older mice

New drug-resistant strain of bird flu appears to retain ability to cause serious disease in humans

GSK's FluLaval Quadrivalent vaccine effective in reducing flu cases in children

Probe mimics pathogen's amino acids, solving mystery behind Chlamydiae cell wall

New antimicrobial coating prevents infections during cold winter months

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

New study aims to determine prevalence of pediatric chronic fatigue syndrome in Chicago area youth

Experimental compound reduces joint inflammation in animal models of rheumatoid arthritis

Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

Tips to relieve dry skin

CUSP project aims to reduce ventilator-associated pneumonia in hospitals

Preparing for better management of Tamiflu-resistant influenza viruses

Children hospitalized for pneumonia have similar outcomes with big gun antibiotics or penicillin

Takeda presents clinical study results of oral proteasome inhibitor MLN9708 in multiple myeloma patients

ImmunoGen presents Phase I trial results of SAR650984 at ASH annual meeting

MUC5B protein plays key role in many lung-related ailments

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in